Polygenic link between blood lipids and amyotrophic lateral sclerosis

Area of Science:

• Genetics and Neurology
• Metabolic Disorders

Background:

• Dyslipidemia, characterized by abnormal blood lipid levels, is frequently observed in patients diagnosed with amyotrophic lateral sclerosis (ALS).
• The precise relationship, including potential causality, between specific blood lipids and ALS risk remains incompletely understood.

Purpose of the Study:

• To investigate the association and causality between key blood lipid profiles and the risk of developing amyotrophic lateral sclerosis (ALS).
• To utilize advanced polygenic analyses and Mendelian randomization to elucidate the genetic underpinnings of the lipid-ALS connection.

Main Methods:

• Genome-wide association study (GWAS) summary statistics were employed for polygenic risk score (PRS) analyses.
• Polygenic risk scores were calculated based on risk alleles for low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), triglycerides, and high-density lipoprotein cholesterol (HDL-C).
• Mendelian randomization (MR) analysis was performed using single nucleotide polymorphisms (SNPs) associated with LDL-C and TC as instrumental variables to infer causality.

Main Results:

• Polygenic risk scores derived from LDL-C and TC risk alleles showed a significant association with an increased risk of ALS.
• Mendelian randomization analysis identified statistically significant causal effects of both LDL-C and TC on ALS risk.
• No significant associations were found between PRS for triglycerides or HDL-C and ALS risk; ALS risk alleles did not associate with studied lipid levels.

Conclusions:

• Elevated levels of LDL-C and TC are confirmed as significant risk factors for amyotrophic lateral sclerosis (ALS).
• The findings strongly suggest a causal relationship between high LDL-C and TC and the pathogenesis of ALS, highlighting potential therapeutic targets.